Latest updates for Vxus

Fresh curated links around VXUS are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Vanguard International ETF Face-Off: VXUS vs. VWO
  • Seeking International Diversification? Is VT or IXUS a Better Core Holding for Long-Term Investors?
  • Meet the Low-Cost Vanguard ETF With Taiwan Semiconductor, Samsung Electronics, SK Hynix, and ASML as Its 4 Largest Holdi

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

fool.com /4 weeks ago

Vanguard International ETF Face-Off: VXUS vs. VWO

VXUS delivered 20.1% returns over one year while maintaining lower costs, but VWO's emerging-market focus offers distinct growth potential for risk-tolerant investors.

Read source
fool.com /5 days ago

Seeking International Diversification? Is VT or IXUS a Better Core Holding for Long-Term Investors?

VT includes U.S. equities with a 30% tech weighting, while IXUS focuses on non-U.S. markets and offers a 3.0% dividend yield for income investors.

Read source
fool.com /1 week ago

Meet the Low-Cost Vanguard ETF With Taiwan Semiconductor, Samsung Electronics, SK Hynix, and ASML as Its 4 Largest Holdi...

International stock ETFs offer superior diversification, lower valuations, and higher yields than S&P 500 ETFs like VOO.

Read source
fool.com /1 month ago

Comparing Global ETFs: Vanguard's VXUS vs. State Street's Climate-Focused NZAC

VXUS offers broader diversification with 8,600+ holdings and lower costs, while NZAC targets climate-aligned companies with concentrated tech exposure.

Read source
fool.com /2 weeks ago

Looking for International Exposure? iShares' EAFE ETF Beats Vanguard's Emerging Markets ETF on Dividend Yield and Stabil...

IEFA delivered $1,555 on a $1,000 five-year investment versus VWO's $1,416, though VWO charges a marginally lower 0.06% expense ratio.

Read source
fool.com /1 month ago

State Street XLV vs. iShares IXJ: Here's How These Healthcare ETFs Stack Up for Investors

XLV's 0.08% expense ratio and 22.7% 1-year return outpace IXJ's global reach, but international diversification comes at a cost.

Read source
fool.com /1 month ago

Vanguard VT vs iShares IEFA: Is Global Diversification or International Exposure the Better Choice for Investors?

Vanguard offers broad global exposure, while iShares focuses strictly on developed markets outside of North America. Here's how the two compare.

Read source
seekingalpha.com /1 month ago

Virtus Ceredex Mid-Cap Value Equity Fund Q2 2026 Commentary

Read source
seekingalpha.com /3 weeks ago

XUDV: New Dividend Booster ETF Off To A Blistering Start, Here's What Can Go Wrong

Read source
seekingalpha.com /2 weeks ago

VYM And HDV: Two Dividend ETFs That Complement Each Other

Read source
fool.com /2 days ago

Vanguard Short-Term Treasury ETF vs Tax-Exempt Bond ETF

VGSH delivers stronger returns and lower volatility, while VTES offers federal tax-exempt income for high-earners.

Read source
fool.com /2 weeks ago

VCSH vs. VTES: Higher Yield or Tax-Free Income?

VCSH offers a 4.6% yield and lower expense ratio, while VTES provides federally tax-free income for conservative investors seeking stable returns.

Read source
fool.com /2 weeks ago

Vanguard VEA vs. State Street SPDW: Which Developed Markets ETF Wins This Tight Race?

Both charge 0.03% in fees, but SPDW yields 3% while VEA offers nearly 3,900 holdings for broader diversification.

Read source
seekingalpha.com /1 month ago

Virtus Stone Harbor Emerging Markets Debt Income Fund Q2 2026 Commentary

Read source
fool.com /1 month ago

Better Healthcare ETF: Vanguard's VHT vs. State Street's Pharmaceuticals-Focused XPH

Vanguard's broader healthcare portfolio charges less and yields more, but State Street's pharma-focused fund has delivered stronger recent gains despite higher volatility.

Read source
seekingalpha.com /1 month ago

Voya Infrastructure, Industrials And Materials Fund Q2 2026 Commentary

Read source
seekingalpha.com /2 weeks ago

VYM: Consistent Dividend ETF, But This 3-ETF Portfolio Looks Better

Read source
seekingalpha.com /1 month ago

Nomura Smid Cap Core Fund Q2 2026 Commentary

Read source
seekingalpha.com /1 week ago

Tradeweb Exchange-Traded Funds Update - September 2026

Read source
fool.com /1 month ago

IXJ vs XPH: Global Healthcare ETF or Pharma Focus?

XPH delivered 57% returns over one year but swung 31% lower at its worst. IXJ offers steadier performance with higher income and $4.2 billion in assets for easier trading.

Read source
fool.com /2 weeks ago

Two International ETFs With Contrasting Styles: iShares MSCI World ETF (URTH) and Emerging Markets ETF (EEM)

URTH's 0.24% expense ratio trails EEM's 0.72%, but EEM delivered 29.2% returns over one year versus URTH's 15.6%.

Read source
fool.com /1 month ago

Vanguard's VT vs. State Street's SPGM: Which Global Stock ETF Is the Better Buy?

SPGM has delivered slightly higher one- and five-year returns, while VT offers lower costs and deeper diversification.

Read source
seekingalpha.com /1 month ago

World Markets Watchlist: September 21, 2026

Read source
seekingalpha.com /3 weeks ago

Equity Market Outlook Q4 2026

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Vxus

seekingalpha.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

fool.com

Recent coverage from public sources
Public source